Literature DB >> 17852832

Decreased serum endoglin level in patients with amyotrophic lateral sclerosis: a preliminary report.

J Iłzecka1.   

Abstract

OBJECTIVES: Angiogenic mechanisms may have a role to play in the neurodegeneration observed in amyotrophic lateral sclerosis (ALS). The aim of the present study was to measure serum angiogenic factor endoglin (ENG) levels in patients with ALS.
MATERIAL AND METHODS: The study involved 25 ALS patients and 25 controls. Concentrations of ENG in serum samples were measured using a human Endoglin/CD105 ELISA kit (R&D Systems, Minneapolis, Minn., USA).
RESULTS: Serum ENG concentrations were 14 % lower in the patients with ALS compared to controls (4.57 versus 3.97 ng/mL; p<0.05). There was no significant difference in serum ENG levels between subgroups of patients with ALS subdivided depending on clinical state, type of ALS onset and duration of the disease (p>0.05). The correlation between serum ENG levels and clinical parameters of ALS was not significant either (p>0.05).
CONCLUSIONS: Results indicate that ENG may be implicated in the pathomechanism of ALS. A decrease in ENG levels, as observed in this study, may accelerate neurodegeneration of motor neurons in ALS through chronic ischaemia caused by impaired perfusion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17852832     DOI: 10.1080/00365510701604628

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  6 in total

1.  Transforming growth factor beta and soluble endoglin in the healthy senior and in Alzheimer's disease patients.

Authors:  B Juraskova; C Andrys; I Holmerova; D Solichova; D Hrnciarikova; H Vankova; T Vasatko; J Krejsek
Journal:  J Nutr Health Aging       Date:  2010-11       Impact factor: 4.075

Review 2.  Biomarkers in amyotrophic lateral sclerosis: facts and future horizons.

Authors:  Pierre-François Pradat; Michel Dib
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

3.  Phenotypic characteristics of human bone marrow-derived endothelial progenitor cells in vitro support cell effectiveness for repair of the blood-spinal cord barrier in ALS.

Authors:  Svitlana Garbuzova-Davis; Jared Ehrhart; Hilmi Mustafa; Alexander Llauget; Kayla J Boccio; Paul R Sanberg; Stanley H Appel; Cesario V Borlongan
Journal:  Brain Res       Date:  2019-09-04       Impact factor: 3.252

4.  Revealing the Proteome of Motor Cortex Derived Extracellular Vesicles Isolated from Amyotrophic Lateral Sclerosis Human Postmortem Tissues.

Authors:  Natasha Vassileff; Laura J Vella; Harinda Rajapaksha; Mitch Shambrook; Amirmohammad Nasiri Kenari; Catriona McLean; Andrew F Hill; Lesley Cheng
Journal:  Cells       Date:  2020-07-16       Impact factor: 6.600

5.  SMA-MAP: a plasma protein panel for spinal muscular atrophy.

Authors:  Dione T Kobayashi; Jing Shi; Laurie Stephen; Karri L Ballard; Ruth Dewey; James Mapes; Brett Chung; Kathleen McCarthy; Kathryn J Swoboda; Thomas O Crawford; Rebecca Li; Thomas Plasterer; Cynthia Joyce; Wendy K Chung; Petra Kaufmann; Basil T Darras; Richard S Finkel; Douglas M Sproule; William B Martens; Michael P McDermott; Darryl C De Vivo; Michael G Walker; Karen S Chen
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

Review 6.  Blood biomarkers for amyotrophic lateral sclerosis: myth or reality?

Authors:  Laura Robelin; Jose Luis Gonzalez De Aguilar
Journal:  Biomed Res Int       Date:  2014-06-02       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.